Hemostemix

Hemostemix

Hemostemix

Hemostemix is a public clinical-stage company that develops innovative blood-derived cell therapies for medical conditions not yet adequately addressed.
Founded
2006
Raised
$4.4M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$4,400,000
Debt financing - 2017
Wood Capital
Team Size
2
Employees
Location
Headquarters
$4,400,000 Debt financing
PE HUB

Hemostemix nets $4.4 mln in debt funding, aims for $8 mln more

Stock markets Legal Privacy